What Does Endovascular Mean? Approach and Procedures Explained

Endovascular means “within a blood vessel.” In practice, the term describes a family of minimally invasive procedures in which doctors thread thin, flexible instruments through the vascular system to diagnose or treat problems from the inside, rather than cutting through tissue to reach a vessel directly. Over the past few decades, the majority of arterial and venous interventions have shifted from traditional open surgery to these percutaneous endovascular techniques.¹ The approach applies across a surprisingly wide range of conditions, from brain aneurysms to blocked leg arteries, and understanding what it involves can make the experience far less intimidating if you or someone you know is facing one of these procedures.

How Doctors Get Inside a Blood Vessel

The basic idea is straightforward: a doctor inserts a needle into a large, accessible artery or vein, usually in the groin (the femoral artery) or the wrist (the radial artery). Through that tiny puncture, they introduce a guidewire and then slide a hollow tube called a catheter over the wire and into the bloodstream. From there, the catheter can be steered through the vascular system to reach the problem area, whether that is in the heart, the brain, the aorta, or the legs.

Two main access sites dominate. The groin has been the traditional starting point because the femoral artery is large and gives a direct route to most of the body’s vessels. The wrist has grown increasingly popular, especially in heart procedures, because it is easier to compress afterward and patients can sit up sooner. A randomized trial comparing the two needle-insertion techniques at the wrist found that the original Seldinger method was faster and more predictable than a modified version, with no increase in bleeding.² Regardless of where the catheter enters, the principle is the same: work through a small skin puncture instead of a large incision.

Seeing Inside the Vessels

Endovascular procedures would be impossible without real-time imaging. The workhorse technology is fluoroscopy, which is essentially a continuous X-ray feed displayed on a monitor. Doctors inject contrast dye through the catheter, and the dye lights up the vessel on the screen, revealing blockages, bulges, or abnormal branches. This technique, called digital subtraction angiography, has long been considered the gold standard.

Its limitation, though, is that it flattens a three-dimensional vessel into a two-dimensional picture. Intravascular ultrasound, or IVUS, addresses that gap. A tiny ultrasound probe mounted on a catheter tip produces a cross-sectional image of the vessel wall from the inside, giving a much more accurate measurement of vessel diameter. Studies have found that angiography consistently underestimates vessel size compared with IVUS.³ That matters because picking the right stent or balloon size depends on knowing the true dimensions of the artery.

In complex cases involving the leg arteries, IVUS guidance has translated into meaningfully better results. One study of patients with complicated blockages in the thigh artery found that IVUS-guided treatment achieved roughly 82% vessel patency at follow-up compared with about 60% for angiography-guided treatment alone.⁴ For simpler blockages, the advantage mostly disappeared. The takeaway is that better imaging tools tend to matter most when the anatomy is difficult.

Repairing Aortic Aneurysms

One of the most well-known endovascular procedures is the repair of abdominal aortic aneurysms, where a weakened section of the body’s largest artery balloons outward and risks rupturing. In an endovascular aneurysm repair (EVAR), the surgeon guides a compressed fabric-and-metal tube called a stent-graft through the femoral artery and positions it inside the aneurysm. Once deployed, the stent-graft acts as a new inner lining, routing blood through the graft and sealing off the weakened wall from the pressure of blood flow. The whole procedure requires only a small incision, takes less time, and allows faster recovery compared with traditional open surgery.⁵

A meta-analysis of randomized trials found that patients who received EVAR had lower perioperative mortality and lower aneurysm-related death rates in the short and medium term compared with those who underwent open repair. The trade-off was that the endovascular group needed more follow-up procedures to address problems with the stent-graft. Over the long term, survival rates between the two approaches tended to converge.⁶ This pattern, where the endovascular approach wins on early safety but needs more maintenance, comes up repeatedly across vascular procedures.

Removing Blood Clots in Stroke

When a large blood clot blocks one of the brain’s major arteries, the result is a devastating ischemic stroke. Mechanical thrombectomy, the endovascular treatment for this, has become the standard of care. A catheter is navigated from the groin up through the aorta and into the neck arteries until it reaches the clot in the brain. A device called a stent retriever is then deployed: it expands within the clot, grabs hold of it, and allows the doctor to pull the clot out.⁷

Newer techniques combine the stent retriever with an aspiration catheter that simultaneously suctions the clot while the stent retriever traps it. This combined approach has been shown to improve the rate of successful clot removal on the first pass and shorten the time from arterial puncture to restored blood flow, without increasing complications.⁸ Time is brain tissue in these cases, so every minute saved translates to potentially less disability for the patient.

Opening Blocked Arteries With Balloons and Stents

Peripheral arterial disease, the progressive narrowing of arteries in the legs, is one of the most common reasons for endovascular treatment. The basic procedure is balloon angioplasty: a catheter with a tiny deflated balloon at its tip is advanced to the narrowed segment, and the balloon is inflated to compress the plaque against the vessel wall and widen the channel. Often a metal mesh stent is left in place to prop the artery open afterward.

A persistent problem with both balloons and bare-metal stents is restenosis, where the treated segment narrows again as cells proliferate on the inner wall. Drug-coated technology was developed to address this. Drug-eluting balloons and drug-eluting stents release medication directly into the vessel wall during treatment, significantly reducing this tissue overgrowth and the need for repeat procedures.⁹ A Cochrane review found that drug-eluting balloons outperformed uncoated balloons in maintaining vessel patency and reducing the need for repeat intervention for up to five years, though the evidence was less clear on whether this translated into differences in quality of life or walking ability.¹⁰

When narrowing occurs below the knee, where arteries are smaller and outcomes are generally worse, a network meta-analysis found that drug-eluting stents had the highest probability of being the best treatment for preventing restenosis, while drug-eluting balloons performed best for avoiding repeat procedures.¹¹ The choice between devices often comes down to the specific location and type of blockage.

Dealing With Heavily Calcified Arteries

Arteries clogged with calcium-hardened plaque present a special challenge. A stiff, calcified blockage may not respond well to a balloon alone, because the balloon cannot fully expand the vessel. Atherectomy devices address this by shaving, drilling, or grinding away the hardened plaque before the balloon or stent goes in. Orbital atherectomy, for example, uses a tiny spinning crown that sands down calcified plaque as it orbits along the artery wall. In a prospective multicenter study, orbital atherectomy reduced the average blockage from about 88% to 35%, and after a follow-up low-pressure balloon inflation, final narrowing averaged just 10%. The technique was most effective on severely calcified plaque and least effective on soft plaque.¹²

Deliberately Blocking Vessels With Embolization

Not every endovascular procedure aims to open a blood vessel. Transcatheter embolization is a common technique in interventional radiology where the goal is to deliberately block blood flow, for instance, to cut off the blood supply feeding a tumor, stop a hemorrhage, or close off an abnormal tangle of blood vessels. A catheter is guided to the target vessel, and an embolic agent is delivered through it. The menu of materials is diverse: metallic coils that trigger local clotting, tiny calibrated beads called microspheres, and liquid agents that harden after injection.¹³

Liquid embolic agents work through different mechanisms. Some polymerize on contact with blood, essentially gluing the vessel shut. Others precipitate when they encounter the aqueous environment inside the body. They are delivered under X-ray guidance so the doctor can watch the agent fill the target vessel in real time and stop injecting before it reaches healthy territory.¹⁴

Endovascular Treatment of Vein Problems

Endovascular tools are not limited to arteries. Deep vein thrombosis, a potentially dangerous blood clot in a major vein, can be treated with catheter-directed thrombolysis, where clot-dissolving medication is delivered directly to the clot site through a catheter rather than infused into the bloodstream at large. Pharmacomechanical thrombectomy takes this further by combining drug delivery with mechanical clot disruption.¹⁵ In cases where a vein is compressed or scarred, dedicated venous stents can be placed to keep it open. IVUS has improved venous diagnosis as well, since vein problems are notoriously difficult to appreciate on standard angiography.¹⁶

How Endovascular Procedures Compare to Open Surgery

The general pattern across vascular diseases is fairly consistent: endovascular procedures cause less physiological stress, produce fewer perioperative complications, and shorten hospital stays. A meta-analysis comparing the two approaches for peripheral artery disease found that complication rates were roughly 9.5% for endovascular surgery versus about 13.6% for open surgery, and hospital stays were about four days shorter.¹⁷ Long-term outcomes, however, tend to be relatively similar between approaches.¹⁸

This convergence over time is an important point that patients sometimes miss. Endovascular repair gets you home faster and back to normal life sooner, but it does not always produce a more durable result. Stent-grafts can develop problems that require additional procedures, and some conditions are better served by a one-time open repair that is tougher to recover from but lasts longer. The decision often depends on your age, overall health, and the specific anatomy of the problem.

Complications Specific to Endovascular Work

Endovascular procedures are minimally invasive, but they are not risk-free. The complications tend to be different from those of open surgery rather than simply fewer.

One complication unique to stent-graft repairs of aortic aneurysms is the endoleak, where blood continues to flow into the aneurysm sac around or through the graft. In a large study of over 2,300 EVAR patients, about 84% had either no endoleak or only a transient one that resolved on its own. The remaining 16% had persistent or new leaks. Persistent type II endoleaks (fed by small branch arteries) were strongly associated with the need for follow-up procedures but, reassuringly, were not linked to reduced long-term survival.¹⁹ Type III endoleaks, caused by disconnections between graft components or fabric tears, are rarer but more concerning when they occur.²⁰

Another risk common to nearly all endovascular procedures is contrast-induced acute kidney injury. The contrast dye that makes blood vessels visible on X-ray can damage the kidneys, particularly in people who already have reduced kidney function. This complication is associated with longer hospital stays and higher mortality.²¹ In one study of patients with prior coronary bypass surgery, roughly 19% developed contrast-induced kidney injury, and the strongest predictors were pre-existing kidney disease and poor heart function rather than the access site used.²² Using the wrist instead of the groin did not make a significant difference in kidney injury rates.²³

Medications Before and After

Blood-thinning drugs are a central part of any endovascular procedure. During the procedure itself, the most common approach is to give a single antiplatelet drug along with heparin, which prevents clots from forming on the catheter and instruments. After the procedure, dual antiplatelet therapy, meaning two anti-clotting drugs taken together, has become the dominant regimen, used in over half of randomized trials involving peripheral arterial disease, and the trend toward dual therapy has increased over time.²⁴

For venous procedures, the medication picture shifts toward anticoagulants rather than antiplatelets, since vein clots form through a different mechanism than arterial ones.²⁵ In neurointerventional procedures, guidelines recommend resuming anticoagulation after the procedure as soon as the risk of a new clot exceeds the risk of bleeding in a given patient.²⁶ In all cases, the medication plan is tailored to the specific procedure and the patient’s individual clotting and bleeding risks.

Recovery and Quality of Life

One of the biggest draws of endovascular procedures is the shorter recovery. Patients typically go home within a day or two instead of spending a week or more in the hospital. In the specific case of aortic aneurysm repair, studies using standardized quality-of-life questionnaires found that EVAR patients reported significantly better physical functioning, less pain, and more vitality at one month compared with open-surgery patients.²⁷ By three months, however, the differences had vanished. A separate review confirmed that while both physical and mental quality-of-life scores favored EVAR at one month, the two approaches were no longer significantly different by six months.²⁸

That early recovery advantage matters more than it might seem on paper. For older patients with heart or lung problems, avoiding a major abdominal operation can mean the difference between a manageable experience and a prolonged, complicated hospital stay. The fact that long-term quality of life converges does not diminish the value of getting through the first weeks in better shape.

The Cost Question

Endovascular procedures are not automatically cheaper than open surgery, despite requiring shorter hospital stays. The devices themselves, such as stent-grafts and drug-coated balloons, are expensive. In a real-world cost analysis of aneurysm repair, the total cost for the initial hospital stay was lower for EVAR than open repair (roughly $32,000 versus $36,000), mainly because of lower fixed costs like room and board. But EVAR’s variable costs, driven by expensive supplies, were actually higher.²⁹

The cost picture changes further when you look at different conditions. A cost-effectiveness analysis of chronic limb-threatening ischemia, the most severe form of leg artery disease, found that bypass surgery was actually both less expensive and slightly more effective over five years than endovascular surgery, making bypass the dominant strategy from a health-economics standpoint.³⁰ For aneurysm repair in a 70-year-old man, by contrast, an older decision-analysis model found endovascular repair to be cost-effective, as long as it produced a meaningful reduction in combined mortality and serious complications compared with open surgery.³¹ There is no blanket answer: cost-effectiveness depends on the condition, the patient’s risk profile, and how many repeat interventions end up being needed.

Who Performs These Procedures

Endovascular procedures sit at the intersection of several medical specialties. Vascular surgeons, interventional radiologists, interventional cardiologists, and neurointerventionalists all perform catheter-based treatments, each in their own anatomical territory. Because peripheral vascular disease, pulmonary embolism, stroke, and aortic emergencies often involve overlapping risks and comorbidities, there has been a growing push toward multidisciplinary vascular teams. A position paper from the American College of Cardiology proposed that coordinated team-based care for conditions like critical limb ischemia and acute stroke has the potential to improve outcomes and reduce costs.³² In practice, this means your treatment plan may involve input from more than one specialist, particularly if your case is complex.

Where the Technology Is Heading

Endovascular therapy has been evolving continuously since it was first described in 1904, initially as a way to inject particles into vascular lesions. The mid-1970s brought microballoons, the early 1990s saw the arrival of detachable coils for brain aneurysms, and the pace of innovation has only accelerated since.³³ One active area of development is augmented reality, which overlays digital images onto the surgeon’s view during the procedure. A scoping review found that augmented reality applications could guide open, robotic, and endovascular surgery while reducing dissection, shortening procedure times, and lowering radiation and contrast exposure.³⁴ Reducing radiation matters both for the patient and for the interventionalists, who accumulate exposure over thousands of procedures across a career. Robotic-assisted catheter navigation is another frontier, aiming to give operators more precise control and potentially allowing experts to guide procedures remotely. These technologies are still maturing, but they signal a field that is far from finished reinventing itself.